The concern about ACE/ARB and COVID-19: Time to hold your horses!

Concern about coronavirus 2019 (COVID-19) morbidity and mortality has drawn attention to the potential role of angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) because the SARS-CoV-2 uses the ACE2 receptor as its point of entry into the body. It is not clear if...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Pharm Assoc (2003)
Autors principals: Pergolizzi, Joseph V., Varrassi, Giustino, Magnusson, Peter, LeQuang, Jo Ann, Leopoulou, Marianna, Paladini, Antonella, Taylor, Robert, Wollmuth, Charles, Breve, Frank
Format: Artigo
Idioma:Inglês
Publicat: Published by Elsevier Inc. on behalf of the American Pharmacists Association. 2020
Matèries:
Science and Practice
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7837157/
https://ncbi.nlm.nih.gov/pubmed/32747165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.japh.2020.06.026
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars